Reviewing Novel Mechanisms in Depression: SAGE-217 in MDD, Axsome Therapeutics' AXS-05, and Recently Approved Esketamine From JNJ.Ticker(s): SAGE, JNJ, AXSM
Name: Dr Deborah Kim - MD
Institution: UPENN & Private Practice
- Clinical associate professor at the Perelman School of Medicine at the University of Pennsylvania.
- Currently manages 100s of patients with depression.
- Specializes in the treatment of perinatal mood and anxiety disorders with extensive experience with treating patients with major medical co-morbidities, PMS/PMDD, menopausal issues and bipolar disorder.
- Prescribes IV ketamine and is clinically certified in treating patients with TMS.
Expert research benefits investors by giving them timely access to unbiased real world perspectives on highly specialized topics. Slingshot Insights' crowdfunded model makes this access available at a fraction of the cost of other expert networks.